Matthes Thomas
Hematology Service, Oncology Department, University Hospital Geneva, Rue Gabrielle Perret-Gentil, 1205 Geneva, Switzerland.
Clinical Pathology Service, Diagnostics Department, University Hospital Geneva, Rue Gabrielle Perret-Gentil, 1205 Geneva, Switzerland.
Int J Mol Sci. 2024 Feb 29;25(5):2847. doi: 10.3390/ijms25052847.
The analysis of hematopoietic stem and progenitor cell populations (HSPCs) is fundamental in the understanding of normal hematopoiesis as well as in the management of malignant diseases, such as leukemias, and in their diagnosis and follow-up, particularly the measurement of treatment efficiency with the detection of measurable residual disease (MRD). In this study, I designed a 20-color flow cytometry panel tailored for the comprehensive analysis of HSPCs using a spectral cytometer. My investigation encompassed the examination of forty-six samples derived from both normal human bone marrows (BMs) and patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) along with those subjected to chemotherapy and BM transplantation. By comparing my findings to those obtained through conventional flow cytometric analyses utilizing multiple tubes, I demonstrate that my innovative 20-color approach enables a more in-depth exploration of HSPC subpopulations and the detection of MRD with at least comparable sensitivity. Furthermore, leveraging advanced analytical tools such as t-SNE and FlowSOM learning algorithms, I conduct extensive cross-sample comparisons with two-dimensional gating approaches. My results underscore the efficacy of these two methods as powerful unsupervised alternatives for manual HSPC subpopulation analysis. I expect that in the future, complex multi-dimensional flow cytometric data analyses, such as those employed in this study, will be increasingly used in hematologic diagnostics.
造血干细胞和祖细胞群体(HSPCs)的分析对于理解正常造血过程、管理白血病等恶性疾病以及对其进行诊断和随访至关重要,特别是在通过检测微小残留病(MRD)来衡量治疗效果方面。在本研究中,我设计了一个20色流式细胞术检测方案,使用光谱细胞仪对HSPCs进行全面分析。我的研究涵盖了46个样本,这些样本来自正常人类骨髓(BM)、急性髓系白血病(AML)和骨髓增生异常综合征(MDS)患者,以及接受化疗和骨髓移植的患者。通过将我的研究结果与使用多管进行的传统流式细胞术分析结果进行比较,我证明了我创新的20色方法能够更深入地探索HSPC亚群,并以至少相当的灵敏度检测MRD。此外,利用t-SNE和FlowSOM学习算法等先进分析工具,我采用二维门控方法进行了广泛的跨样本比较。我的结果强调了这两种方法作为手动HSPC亚群分析的强大无监督替代方法的有效性。我预计,未来像本研究中使用的复杂多维流式细胞术数据分析将越来越多地应用于血液学诊断。